WhiteOak Capital Pharma and Heathcare Fund
Sectoral/ Thematic · WhiteOak Capital Asset Management Limited
Be warned: in its worst stretch, ₹1 lakh briefly shrank to about ₹84,610. Expect meaningful ups and downs on the way.
New to fund research? Start with the 5-minute guide. The detailed numbers below back all of this up.WhiteOak Capital Pharma and Heathcare Fund is a Sectoral/ Thematic fund from WhiteOak Capital Asset Management Limited. It has a track record of about 2.6 years. As of the latest data it carries an RS rating of 95/99 (its recent momentum versus category peers). The current NAV is ₹17.39 (as of 2026-09-16).
Growth of ₹100 - last 3 years
WhiteOak Capital Pharma and Heathcare Fund returns: last 1, 3, 5 and 10 years
| Period | This fund | Category average |
|---|---|---|
| 1 month | -0.83% | -3.47% |
| 3 months | 9.79% | 2.0% |
| 6 months | 23.54% | 10.56% |
| 1 year | 20.01% | 4.78% |
Its trailing one-year return is 20.01%. Trailing returns flatter or disappoint depending on the end date you pick - the year-by-year and rolling-return sections below are a fairer read.
Year-by-year returns
| Year | WhiteOak Capital Pharm | Benchmark |
|---|---|---|
| 2025 | +1.8% | -2.9% |
| 2026 | +22.5% | +15.2% |
Calendar-year returns show how bumpy the ride really was - an average hides the good years and the ugly ones.
Risk & drawdowns
| Measure | This fund | Category average |
|---|---|---|
| Worst drawdown (lifetime) | -15.39% | -26.37% |
| Worst drawdown (3Y) | -15.39% | -20.9% |
| Volatility (1Y) | 15.84% | 19.02% |
| Sharpe (3Y) | 1.08 | 0.31 |
| Sortino (3Y) | 1.72 | 0.82 |
| Beta (3Y) | 0.91 | 0.91 |
| Alpha (3Y) | 10.26% | 6.12% |
| Up capture | 102.0% | 97.13% |
| Down capture | 79.2% | 81.47% |
| Bull-market return | 42.4% | 30.78% |
| Bear-market return | -0.5% | -23.76% |
Timing matters more than people admit: the best possible 1-year stretch in WhiteOak Capital Pharma and Heathcare Fund (starting 2024-03-21) gained 35.5%, while the worst (starting 2025-01-23) still made 0.6%. The worst peak-to-bottom fall WhiteOak Capital Pharma and Heathcare Fund has ever put investors through is -15.39% - the real test of whether you'd have stayed invested. In falling markets (Nifty below its 200-day average) it has returned about -0.5% annualised, versus 42.4% in rising markets. It has captured roughly 102.0% of its benchmark's up-moves and 79.2% of its down-moves.
How WhiteOak Capital Pharma and Heathcare Fund behaves when markets fall
When the market is falling (the Nifty below its 200-day average), WhiteOak Capital Pharma and Heathcare Fund has historically returned about -0.5% annualised, versus roughly 42.4% when the market is rising. Its deepest fall on record is -15.39%. Right now it sits about 2.07% below its all-time high (last hit 2026-09-11). The real question isn't the average year - it's whether you could hold on through the worst one.
How WhiteOak Capital Pharma and Heathcare Fund ranks in its category
Percentile versus its ~946 category peers - 100th is best-in-class, 50th is average. This is the fairest apples-to-apples read.
Consistency (rolling returns)
Rolling-return data isn't available for this fund yet.
What WhiteOak Capital Pharma and Heathcare Fund holds
Its latest monthly portfolio disclosure. This is what your money actually owns.
Top holdings
Sector allocation
The top 10 holdings make up 44.9% of the portfolio, across 49 stocks. A higher concentration means the fund's fortunes ride on fewer names.
Portfolio overlap with similar funds
WhiteOak Capital Pharma and Heathcare Fund shares HDFC Transportation and Logistics Fund (0%), LIC MF Healthcare Fund (0%), ICICI Prudential Transportation And Logistics Fund (0%) of its portfolio with these category peers (overlap = the slice of the two portfolios invested in the same stocks). The lower the overlap, the more genuinely different the portfolios are.
Who manages WhiteOak Capital Pharma and Heathcare Fund - and how good are they?
WhiteOak Capital Pharma and Heathcare Fund is managed by Piyush Baranwal, Ramesh Mantri and Trupti Agrawal. Below is each manager's complete track record - every fund they currently run, judged on the same numbers as everything else on this page - so you can see whether this fund is in strong hands or is the outlier in a weak book.
Piyush Baranwal's full record
Piyush Baranwal currently runs 18 funds, across Balanced Hybrid Fund, ELSS, Equity Savings, Flexi Cap Fund and more, with about ₹33,792 Cr under management. The book's average King Score is 90.3/100. Their strongest fund by King Score is WhiteOak Capital Large Cap Fund (97/100); WhiteOak Capital Pharma and Heathcare Fund ranks #8 of 18 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WhiteOak Capital Large Cap Fund | 88 | 97 | 0.6% | 4.2% | -1.4% | 12.2% | n/a | n/a | 0.4 | 17.7% | -15.2% |
| 2 | WhiteOak Capital Mid Cap Fund | 96 | 96 | 4.1% | 18.5% | 12.2% | 21.0% | n/a | n/a | 0.87 | 27.1% | -19.3% |
| 3 | WhiteOak Capital ELSS Tax Saver Fund | 80 | 96 | 3.2% | 11.7% | 2.1% | 15.3% | n/a | n/a | 0.58 | 21.7% | -16.4% |
| 4 | WhiteOak Capital Flexi Cap Fund | 71 | 87 | 2.9% | 10.7% | 2.8% | 13.8% | n/a | n/a | 0.5 | 20.3% | -15.6% |
| 5 | WhiteOak Capital Multi Asset Allocation Fund | 97 | 86 | 2.7% | 5.6% | 11.6% | 16.5% | n/a | n/a | 1.72 | n/a | -4.8% |
| 6 | WhiteOak Capital Liquid Fund | 86 | 85 | 1.7% | 3.4% | 6.5% | 6.9% | 6.2% | n/a | 0.94 | 5.3% | -0.1% |
| 7 | WhiteOak Capital Ultra Short Duration Fund | 83 | 85 | 1.8% | 3.6% | 6.5% | 7.0% | 6.3% | n/a | 1.02 | 5.9% | -0.2% |
| 8 | WhiteOak Capital Pharma and Heathcare Fund (this page) | 95 | n/a | 9.8% | 23.5% | 20.0% | n/a | n/a | n/a | 1.08 | n/a | -15.4% |
| 9 | WhiteOak Capital Equity Savings Fund | 93 | n/a | 2.3% | 4.7% | 6.9% | n/a | n/a | n/a | 1.11 | n/a | -3.6% |
| 10 | Whiteoak Capital Large & Mid Cap Fund | 84 | n/a | 1.9% | 9.2% | 3.9% | n/a | n/a | n/a | 0.43 | n/a | -16.0% |
| 11 | WhiteOak Capital Special Opportunities Fund | 83 | n/a | 5.7% | 19.2% | 11.8% | n/a | n/a | n/a | 0.68 | n/a | -17.0% |
| 12 | WhiteOak Capital Digital Bharat Fund | 81 | n/a | 9.8% | 21.9% | -2.4% | n/a | n/a | n/a | -0.22 | n/a | -24.7% |
| 13 | WhiteOak Capital Multi Cap Fund | 76 | n/a | 3.5% | 14.1% | 5.8% | n/a | n/a | n/a | 0.77 | n/a | -16.9% |
| 14 | WhiteOak Capital Balanced Hybrid Fund | 66 | n/a | 2.1% | 5.4% | 3.0% | n/a | n/a | n/a | 0.61 | n/a | -8.3% |
| 15 | WhiteOak Capital Banking & Financial Services Fund | 51 | n/a | 0.7% | 6.5% | 3.7% | n/a | n/a | n/a | 0.28 | n/a | -15.7% |
| 16 | WhiteOak Capital Quality Equity Fund | 48 | n/a | 2.2% | 8.4% | -3.7% | n/a | n/a | n/a | -0.33 | n/a | -16.2% |
| 17 | WhiteOak Capital ESG Best-In-Class Strategy Fund | 39 | n/a | 1.4% | 6.1% | -5.1% | n/a | n/a | n/a | -0.35 | n/a | -17.1% |
| 18 | WhiteOak Capital Consumption Opportunities Fund | n/a | n/a | 3.9% | 14.1% | n/a | n/a | n/a | n/a | n/a | n/a | -11.7% |
Ramesh Mantri's full record
Ramesh Mantri currently runs 16 funds, across Balanced Hybrid Fund, ELSS, Equity Savings, Flexi Cap Fund and more, with about ₹33,443 Cr under management. The book's average King Score is 92.4/100. Their strongest fund by King Score is WhiteOak Capital Large Cap Fund (97/100); WhiteOak Capital Pharma and Heathcare Fund ranks #6 of 16 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WhiteOak Capital Large Cap Fund | 88 | 97 | 0.6% | 4.2% | -1.4% | 12.2% | n/a | n/a | 0.4 | 17.7% | -15.2% |
| 2 | WhiteOak Capital Mid Cap Fund | 96 | 96 | 4.1% | 18.5% | 12.2% | 21.0% | n/a | n/a | 0.87 | 27.1% | -19.3% |
| 3 | WhiteOak Capital ELSS Tax Saver Fund | 80 | 96 | 3.2% | 11.7% | 2.1% | 15.3% | n/a | n/a | 0.58 | 21.7% | -16.4% |
| 4 | WhiteOak Capital Flexi Cap Fund | 71 | 87 | 2.9% | 10.7% | 2.8% | 13.8% | n/a | n/a | 0.5 | 20.3% | -15.6% |
| 5 | WhiteOak Capital Multi Asset Allocation Fund | 97 | 86 | 2.7% | 5.6% | 11.6% | 16.5% | n/a | n/a | 1.72 | n/a | -4.8% |
| 6 | WhiteOak Capital Pharma and Heathcare Fund (this page) | 95 | n/a | 9.8% | 23.5% | 20.0% | n/a | n/a | n/a | 1.08 | n/a | -15.4% |
| 7 | WhiteOak Capital Equity Savings Fund | 93 | n/a | 2.3% | 4.7% | 6.9% | n/a | n/a | n/a | 1.11 | n/a | -3.6% |
| 8 | Whiteoak Capital Large & Mid Cap Fund | 84 | n/a | 1.9% | 9.2% | 3.9% | n/a | n/a | n/a | 0.43 | n/a | -16.0% |
| 9 | WhiteOak Capital Special Opportunities Fund | 83 | n/a | 5.7% | 19.2% | 11.8% | n/a | n/a | n/a | 0.68 | n/a | -17.0% |
| 10 | WhiteOak Capital Digital Bharat Fund | 81 | n/a | 9.8% | 21.9% | -2.4% | n/a | n/a | n/a | -0.22 | n/a | -24.7% |
| 11 | WhiteOak Capital Multi Cap Fund | 76 | n/a | 3.5% | 14.1% | 5.8% | n/a | n/a | n/a | 0.77 | n/a | -16.9% |
| 12 | WhiteOak Capital Balanced Hybrid Fund | 66 | n/a | 2.1% | 5.4% | 3.0% | n/a | n/a | n/a | 0.61 | n/a | -8.3% |
| 13 | WhiteOak Capital Banking & Financial Services Fund | 51 | n/a | 0.7% | 6.5% | 3.7% | n/a | n/a | n/a | 0.28 | n/a | -15.7% |
| 14 | WhiteOak Capital Quality Equity Fund | 48 | n/a | 2.2% | 8.4% | -3.7% | n/a | n/a | n/a | -0.33 | n/a | -16.2% |
| 15 | WhiteOak Capital ESG Best-In-Class Strategy Fund | 39 | n/a | 1.4% | 6.1% | -5.1% | n/a | n/a | n/a | -0.35 | n/a | -17.1% |
| 16 | WhiteOak Capital Consumption Opportunities Fund | n/a | n/a | 3.9% | 14.1% | n/a | n/a | n/a | n/a | n/a | n/a | -11.7% |
Trupti Agrawal's full record
Trupti Agrawal currently runs 16 funds, across Balanced Hybrid Fund, ELSS, Equity Savings, Flexi Cap Fund and more, with about ₹33,443 Cr under management. The book's average King Score is 92.4/100. Their strongest fund by King Score is WhiteOak Capital Large Cap Fund (97/100); WhiteOak Capital Pharma and Heathcare Fund ranks #6 of 16 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WhiteOak Capital Large Cap Fund | 88 | 97 | 0.6% | 4.2% | -1.4% | 12.2% | n/a | n/a | 0.4 | 17.7% | -15.2% |
| 2 | WhiteOak Capital Mid Cap Fund | 96 | 96 | 4.1% | 18.5% | 12.2% | 21.0% | n/a | n/a | 0.87 | 27.1% | -19.3% |
| 3 | WhiteOak Capital ELSS Tax Saver Fund | 80 | 96 | 3.2% | 11.7% | 2.1% | 15.3% | n/a | n/a | 0.58 | 21.7% | -16.4% |
| 4 | WhiteOak Capital Flexi Cap Fund | 71 | 87 | 2.9% | 10.7% | 2.8% | 13.8% | n/a | n/a | 0.5 | 20.3% | -15.6% |
| 5 | WhiteOak Capital Multi Asset Allocation Fund | 97 | 86 | 2.7% | 5.6% | 11.6% | 16.5% | n/a | n/a | 1.72 | n/a | -4.8% |
| 6 | WhiteOak Capital Pharma and Heathcare Fund (this page) | 95 | n/a | 9.8% | 23.5% | 20.0% | n/a | n/a | n/a | 1.08 | n/a | -15.4% |
| 7 | WhiteOak Capital Equity Savings Fund | 93 | n/a | 2.3% | 4.7% | 6.9% | n/a | n/a | n/a | 1.11 | n/a | -3.6% |
| 8 | Whiteoak Capital Large & Mid Cap Fund | 84 | n/a | 1.9% | 9.2% | 3.9% | n/a | n/a | n/a | 0.43 | n/a | -16.0% |
| 9 | WhiteOak Capital Special Opportunities Fund | 83 | n/a | 5.7% | 19.2% | 11.8% | n/a | n/a | n/a | 0.68 | n/a | -17.0% |
| 10 | WhiteOak Capital Digital Bharat Fund | 81 | n/a | 9.8% | 21.9% | -2.4% | n/a | n/a | n/a | -0.22 | n/a | -24.7% |
| 11 | WhiteOak Capital Multi Cap Fund | 76 | n/a | 3.5% | 14.1% | 5.8% | n/a | n/a | n/a | 0.77 | n/a | -16.9% |
| 12 | WhiteOak Capital Balanced Hybrid Fund | 66 | n/a | 2.1% | 5.4% | 3.0% | n/a | n/a | n/a | 0.61 | n/a | -8.3% |
| 13 | WhiteOak Capital Banking & Financial Services Fund | 51 | n/a | 0.7% | 6.5% | 3.7% | n/a | n/a | n/a | 0.28 | n/a | -15.7% |
| 14 | WhiteOak Capital Quality Equity Fund | 48 | n/a | 2.2% | 8.4% | -3.7% | n/a | n/a | n/a | -0.33 | n/a | -16.2% |
| 15 | WhiteOak Capital ESG Best-In-Class Strategy Fund | 39 | n/a | 1.4% | 6.1% | -5.1% | n/a | n/a | n/a | -0.35 | n/a | -17.1% |
| 16 | WhiteOak Capital Consumption Opportunities Fund | n/a | n/a | 3.9% | 14.1% | n/a | n/a | n/a | n/a | n/a | n/a | -11.7% |
A caveat worth keeping: funds often have co-managers, and results belong to the whole team and process rather than one person. A manager's book tells you about their range and consistency, not a guarantee of skill.
Cost & fund basics
| Detail | Value |
|---|---|
| Expense ratio (Direct) | 0.6% |
| Exit load | ≈1% if redeemed within 1 year (typical) |
| Minimum investment | ₹500 |
| Fund size (AUM) | ₹664 Cr |
| Age | 2.6 years |
| Plan / Option | Direct · Growth |
| Benchmark | NIFTY_PHARMA |
How WhiteOak Capital Pharma and Heathcare Fund compares to peers
| Fund | RS | King | 3Y CAGR |
|---|---|---|---|
| HDFC Transportation and Logistics Fund | 82 | 89 | 24.1% |
| LIC MF Healthcare Fund | 91 | 87 | 21.4% |
| ICICI Prudential Transportation And Logistics Fund | 78 | 87 | 21.1% |
| ICICI Prudential Innovation Fund | 56 | 87 | 17.8% |
| HDFC Defence Fund | 87 | 83 | 36.0% |
| Kotak Manufacture in India Fund | 81 | 83 | 19.1% |
Overlap warning: funds in the same category often own many of the same stocks - holding several rarely adds the diversification people expect.
What these numbers mean
RS rating (1-99) ranks a fund's recent momentum against its category - higher is stronger right now. King Score (0-100) is a long-term quality composite (returns, consistency, drawdown, risk-adjusted return) versus peers. Max drawdown is the worst peak-to-bottom fall the fund has ever experienced. Rolling returns test every possible start date, so one lucky (or unlucky) entry point can't distort the picture. Every formula behind this page is public - see how we calculate every number.
WhiteOak Capital Pharma and Heathcare Fund review: the bottom line
Related
Frequently asked questions
Is WhiteOak Capital Pharma and Heathcare Fund a good mutual fund?
That depends on your goals and risk tolerance - this is descriptive research, not advice. On the numbers, WhiteOak Capital Pharma and Heathcare Fund scores RS 95/99 within its category, and its worst drawdown was -15.39%. Compare those against your needs and the peer table above.
What is the NAV of WhiteOak Capital Pharma and Heathcare Fund today?
The latest NAV is ₹17.39 (as of 2026-09-16). NAV (net asset value) is the per-unit price of the fund, published every business day by the AMC.
What is the expense ratio of WhiteOak Capital Pharma and Heathcare Fund?
The Direct-plan expense ratio is 0.6% a year. The Direct plan is cheaper than the Regular plan because it carries no distributor commission - over decades that gap compounds meaningfully.
Who is the fund manager of WhiteOak Capital Pharma and Heathcare Fund?
WhiteOak Capital Pharma and Heathcare Fund is managed by Piyush Baranwal; Ramesh Mantri; Trupti Agrawal; Dheeresh Pathak; Ashish Agrawal.
Is WhiteOak Capital Pharma and Heathcare Fund safe? How risky is it?
No market-linked fund is 'safe' in the fixed-deposit sense - the honest question is how deep its falls get. Its worst historical drawdown was -15.39% - ₹1 lakh briefly becoming about ₹84,610. As a sectoral & thematic fund, its risk profile is typical of that category. Look at the drawdown, volatility and bear-market figures above and ask whether you could stay invested through the bad stretches.
Is WhiteOak Capital Pharma and Heathcare Fund tax-efficient / what about capital gains?
As a sectoral & thematic fund, gains follow the rules for its asset class - equity-oriented funds are taxed differently from debt. All returns on this page are pre-tax; your actual post-tax return depends on your holding period and slab. This is descriptive information, not tax advice.
Direct or Regular plan - which is shown here?
All figures on this page are for the Direct-Growth plan (no distributor commission, lower cost). Returns are pre-tax; capital-gains tax depends on your own holding period and slab.
See WhiteOak Capital Pharma and Heathcare Fund live in the MF Terminal
Everything above is a static snapshot. The terminal is where you actually research it:
- Interactive price chart with EMAs & RSI
- The RS line plotted against its benchmark
- Full holdings, sector mix & portfolio overlap
- Point-in-time backtester & portfolio doctor
- Compare it side-by-side with any peer
- Screen 1,600+ funds on the same metrics
Data: AMFI NAV history, NSE indices, BSE StAR and monthly disclosures. All figures are pre-tax. Descriptive research and education only - nothing here is investment advice or a recommendation to buy, sell or hold any fund. Past performance does not guarantee future returns.